Skip To Main Content
Hoejun Kwon on Muck Rack

Hoejun Kwon

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hoejun

Contact Hoejun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Projected cancer burden attributable to population aging: Insight from a rapidly aging society

|
By Hoejun Kwon, Yoon-Jung Choi, Hyunsoon Cho, Minh-Thao Tu
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT The authors have no conflict of interest. Supporting Information Filename Description ijc70125-sup-0001-TableS1-S5-FigureS1-S3.pdfPDF document, 770.7 KB TABLE S1. International Classification of Diseases, Tenth Revision (ICD-10) code for cancer types. TABLE S2. Selection for aging-related cancer incidence in 2021. TABLE S3. Selection for aging-related cancer mortality in 2022. TABLE S4.
Open in Who Shared Issue with article?

Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancer

|
By Hyunsoon Cho, Hyun Kim, Hoejun Kwon, Hyung-Min Ahn
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT Ji-Youn Han reports receiving research grants from Roche, ONO, Pfizer, and Takeda; consulting fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Abion, and J INTS BIO; and honoraria for lectures from AstraZeneca, Bristol-Myers Squibb, Merck, Takeda, and Novartis. Youngjoo Lee reports receiving consulting fees from Roche, Merck, Yuhan, and Bayer. The other authors declare no conflicts of interest.
Open in Who Shared Issue with article?
See all 2 articles